Miami Valves 2024: 35% Discount for SOLACI Members!

From February 1 to 3, 2024, Miami Valves 2024 will be held in Miami, Florida, US, at the Miami Marriot Byscayne Bay Hotel.

This event has been founded by faculty members of Miami University centers of excellence and complemented by key opinion leaders from around the world; here you will be able to attend powerful lectures and case presentations delivered by the most brilliant minds in the field of transcatheter therapies.

SOLACI provides institutional support to the Congress and, as such, we are offering an exclusive 35% discount on registration fees for our members. 

35% off in registration fees for SOLACI members!

To access this benefit, write to webservices@solaci.org and jornadas@solaci.org with the subject “I want the discount for Miami Valves 2024”. In the body of the email you must include your Name, Surname, Nationality and Email. Once we certify your membership status, the discount code with which you can register for the event will be shared.

Do not miss this opportunity!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....